Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
63,316,479
-
Share change
-
-5,021,188
-
Total reported value
-
$2,600,052,259
-
Put/Call ratio
-
31%
-
Price per share
-
$41.10
-
Number of holders
-
254
-
Value change
-
-$177,983,391
-
Number of buys
-
114
-
Number of sells
-
131
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2017
As of 31 Dec 2017,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
254 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,316,479 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, JANUS HENDERSON GROUP PLC, STATE STREET CORP, Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, Standard Life Aberdeen plc, Van Berkom & Associates Inc., and ROYAL BANK OF CANADA.
This page lists
254
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.